ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites

J Exp Med. 2019 Dec 2;216(12):2714-2723. doi: 10.1084/jem.20180610. Epub 2019 Oct 3.

Abstract

Host immunity to parasitic nematodes requires the generation of a robust type 2 cytokine response, characterized by the production of interleukin 13 (IL-13), which drives expulsion. Here, we show that infection with helminths in the intestine also induces an ILC2-driven, IL-13-dependent goblet cell hyperplasia and increased production of mucins (Muc5b and Muc5ac) at distal sites, including the lungs and other mucosal barrier sites. Critically, we show that type 2 priming of lung tissue through increased mucin production inhibits the progression of a subsequent lung migratory helminth infection and limits its transit through the airways. These data show that infection by gastrointestinal-dwelling helminths induces a systemic innate mucin response that primes peripheral barrier sites for protection against subsequent secondary helminth infections. These data suggest that innate-driven priming of mucus barriers may have evolved to protect from subsequent infections with multiple helminth species, which occur naturally in endemic areas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cross Protection / immunology
  • Goblet Cells / cytology
  • Goblet Cells / metabolism
  • Hyperplasia
  • Immunity, Innate*
  • Interleukin-13 / metabolism
  • Intestinal Mucosa / immunology
  • Intestinal Mucosa / metabolism
  • Intestinal Mucosa / parasitology
  • Lymphocyte Subsets / immunology*
  • Lymphocyte Subsets / metabolism*
  • Male
  • Mice
  • Mice, Knockout
  • Mucins / biosynthesis
  • Mucous Membrane / immunology*
  • Mucous Membrane / metabolism*
  • Mucus / metabolism*
  • Trichinella spiralis / immunology
  • Trichinellosis / immunology
  • Trichinellosis / parasitology

Substances

  • Interleukin-13
  • Mucins